Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$25,000.00

Development and testing of a multiplex microbead assay on a plastic microfluidic device

FY 2015-16

Summary
Cytodiagnostics is an Ontario-based biotechnology company and a leader in the development of nanotechnology products for the life sciences market. The company has identified a market opportunity to integrate their nanoparticle and microbead technology with microfluidic systems. These systems, also commonly referred to as ""lab-on-a-chip"" devices, take advantage of physical forces at the microscale to precisely control and manipulate fluids in miniaturized geometries. Because of their intricate geometric features, these devices are ideal in applications involving micron-sized materials such as biological samples, and thus are currently receiving significant attention in life sciences research and the biotech industry. Cytodiagnostics has conceptualized a new multiplex microbead assay on a microfluidic chip that would represent a major advance over existing products in the market, but progress has been hindered by long turnaround times and high development costs. The main goal of this project is to use simple and low-cost fabrication processes, recently developed in Dr. Young's laboratory, to streamline the development process for Cytodiagnostics' multiplex microbead assay. The collaborative effort will involve design and fabrication of a plastic microfluidic device that interfaces with a high-throughput array of microwells, enabling efficient deposition of microbeads into the array. The array can then be amenable to fluorescence imaging, detection, and analysis. By expediting the development process, Cytodiagnostics will be able to offer new, innovative products to the market in less time, thereby further demonstrating their leadership in the biotech industry, and strengthening Canada's reputation as a hub for biotech innovations.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
483885-2015
Name nom
Young, EdmondWaiKeung
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Partie
1
Nb partie
1
Application title
Development and testing of a multiplex microbead assay on a plastic microfluidic device
Keyword
NSERC
Application summary
Cytodiagnostics is an Ontario-based biotechnology company and a leader in the development of nanotechnology products for the life sciences market. The company has identified a market opportunity to integrate their nanoparticle and microbead technology with microfluidic systems. These systems, also commonly referred to as ""lab-on-a-chip"" devices, take advantage of physical forces at the microscale to precisely control and manipulate fluids in miniaturized geometries. Because of their intricate geometric features, these devices are ideal in applications involving micron-sized materials such as biological samples, and thus are currently receiving significant attention in life sciences research and the biotech industry. Cytodiagnostics has conceptualized a new multiplex microbead assay on a microfluidic chip that would represent a major advance over existing products in the market, but progress has been hindered by long turnaround times and high development costs. The main goal of this project is to use simple and low-cost fabrication processes, recently developed in Dr. Young's laboratory, to streamline the development process for Cytodiagnostics' multiplex microbead assay. The collaborative effort will involve design and fabrication of a plastic microfluidic device that interfaces with a high-throughput array of microwells, enabling efficient deposition of microbeads into the array. The array can then be amenable to fluorescence imaging, detection, and analysis. By expediting the development process, Cytodiagnostics will be able to offer new, innovative products to the market in less time, thereby further demonstrating their leadership in the biotech industry, and strengthening Canada's reputation as a hub for biotech innovations.